SELECTIVE ACETYLENIC ‘SUICIDE’ AND REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE TYPES A AND B
Open Access
- 1 May 1981
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 73 (1) , 55-64
- https://doi.org/10.1111/j.1476-5381.1981.tb16771.x
Abstract
1 A number of aromatic-N-propargyl (acetylenic) compounds and indoleamines were tested for their inhibitory action on monoamine oxidase (MAO) type A and type B using the substrates 5-hydroxytryptamine (5-HT), β-phenylethylamine (PEA) and dopamine. 2 Structure activity studies with aromatic-N-propragyl (acetylenic) derivatives have shown that MAO inhibitory potency is least dependent on the aromatic portion of the compounds. N-methylated propargyl derivatives are the most active and replacement of the methyl group with a higher alkyl or aromatic group results in significant reduction of activity. The triple bond in the N-propargyl portion is absolutely essential for activity and must be β-to the nitrogen. It is the acetylenic group that gives these compounds their irreversible MAO inhibitory property. 3 The present study has indicated that since the acetylenic compounds resemble the enzyme substrates the distance between the aromatic ring and the N-propargyl terminal is crucial in designating the type A or type B MAO inhibitory property. For MAO type A inhibition, a distance equivalent to at least three carbon units is required, while for the inhibition of the B type enzyme this distance can be 1 or 2 carbon units. 4 The compounds AGN-1133 and AGN-1135 show most promise in Parkinson's disease or as anti-depressants because of their irreversible selective type B MAO inhibition in vitro and in vivo. 5 A number of indoleamine derivatives were found to be reversible selective type A inhibitors.Keywords
This publication has 25 references indexed in Scilit:
- L-deprenyl, a selective monoamine oxidase type-b inhibitor in endogenous depressionLife Sciences, 1980
- Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO ?type B? inhibitorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Overview of present day treatment of Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- On the mode of action of L-deprenyl in the human central nervous systemJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- Monoamine oxidase A and B: A useful concept?Biochemical Pharmacology, 1978
- Novel (−)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their actionBiochemical Pharmacology, 1978
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- STRUCTURE‐ACTIVITY RELATIONS IN THE PARGYLINE SERIESAnnals of the New York Academy of Sciences, 1963